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Abstract Tuning of transcription is a powerful process tech-
nological tool for efficient recombinant protein production in
Escherichia coli. Many challenges such as product toxicity,
formation of inclusion bodies, cell death, and metabolic bur-
den are associated with non-suitable (too high or too low)
levels of recombinant protein expression. Tunable expression
systems allow adjusting the recombinant protein expression
using process technological means. This enables to exploit the
cell’s metabolic capacities to a maximum. Within this article,
we review genetic and process technological aspects of tun-
able expression systems in E. coli, providing a roadmap for
the industrial exploitation of the reviewed technologies. We
attempt to differentiate the term Bexpression tuning^ from its
inflationary use by providing a concise definition and high-
light interesting fields of application for this versatile new
technology. Dependent on the type of inducer (metabolizable
or non-metabolizable), different process strategies are re-
quired in order to achieve tuning. To fully profit from the
benefits of tunable systems, an independent control of growth
rate and expression rate is indispensable. Being able to tackle
problems such as long-term culture stability and constant
product quality expression tuning is a promising enabler for
continuous processing in biopharmaceutical production.
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Introduction
The relevance of the gram-negative bacterium Escherichia
coli for the basic biotechnological research as well as for in-
dustrial exploitation is outstanding. E. coli served as the pri-
mary model organism within the development of modern bio-
technology. As a consequence, researchers today have access
to a broad spectrum of genetic tools and cultivation tech-
niques, enabling simple and predictable genetic manipulation
and cultivation on inexpensive media to high cell densities. As
regards industrial exploitation, E. coli emerged as the primary
production workhorse for the biotechnological production of
primary and secondary metabolites as well as recombinant
proteins. This is reflected by the fact that 29 % of all biophar-
maceutical products approved as biopharmaceuticals between
2010 and July 2014 are produced in E. coli (Walsh 2014).
Overall productivity and product quality obtained from
E. coli processes is determined by the complex interplay of
processing mode and the product to be produced as well as the
expression system applied.
The main challenges of recombinant protein production in
E. coli are associated with non-suitable (too high or too low)
level of recombinant expression:
1. First, high-level expression and the presence of foreign
plasmids drain the hosts’ metabolic resources (often re-
ferred to as metabolic load or metabolic burden) (Bentley
et al. 2009; Bienick et al. 2014; Glick 1995; Mairhofer
et al. 2013). Metabolic load often resulting in depletion of
amino acids or aminoacyl-tRNAs and triggering heat-
shock response can therefore ultimately affect product
Lukas Marschall and Patrick Sagmeister contributed to this work equally.
* Christoph Herwig
Christoph.Herwig@tuwien.ac.at
1 Institute of Chemical Engineering, Research Area Biochemical
Engineering, Vienna University of Technology, Vienna, Austria
2 Exputec GmbH, Vienna, Austria
3 Christian Doppler Laboratory for Mechanistic and Physiological
Methods for Improved Bioprocesses, Vienna University of
Technology, Gumpendorferstraße 1a/166-4, 1060 Vienna, Austria
Appl Microbiol Biotechnol (2016) 100:5719–5728
DOI 10.1007/s00253-016-7550-4
quality-related issues (specific activity, stability, and im-
munogenicity) and product quantity-related issues (prod-
uct degradation, lower specific product yields, lower bio-
mass yields, or shorter culture stability).
2. Second, high-level expression of recombinant products
can lead to the formation of unfolded or partially folded
insoluble protein aggregates known as inclusion bodies
which show no catalytic function or activity (Baig et al.
2014; Kane and Hartley 1991).
3. Third, the production of many recombinant products, es-
pecially proteins containing disulfide bridges, demands
translocation between compartments of the E. coli cell
factory (Baneyx and Mujacic 2004). Here, too high levels
of recombinant protein expression can lead to the
blocking of translocation pathways.
The mentioned challenges are either fully or to a great
extent caused by recombinant protein expression. The level
of recombinant protein expression is affected by the strength
of the expression system which involves the strength of the
promoter used and the plasmid copy number (Keasling 1999)
as well as the process technological parameters such as tem-
perature and the specific growth rate (Hellmuth et al. 1994;
Rodríguez-Carmona et al. 2012). It is frequently observed that
a reduction of the protein expression level leads to increased
end product titers, since the cells can be maintained in a pro-
ductive state for a longer time (Sagmeister et al. 2014;
Sagmeister et al. 2013b) (Fig. 1).
BExpression tuning,^ also referred to as Bfine-tuning of
protein production^ and Bmodulation of expression,^ intends
to solve the aforementioned challenges by providing a tech-
nological framework to adjust recombinant protein expression
online to a level which is optimal for protein folding, protein
translocation, and long-term productivity. Hence, tuning al-
lows exploiting the cell factory to a maximum.
To our knowledge, expression tuning has not been reviewed
so far. With this review article, we are the first to aim at giving a
concise and comprehensive overview of current state-of-the-art
methods and technologies for expression tuning. First, we brief-
ly discuss the role of continuous processing in the production of
biopharmaceuticals and the benefits of its application in com-
bination with expression tuning. Second, we discuss the con-
temporary scientific conception of expression tuning and aim at
the proposition of a sound and comprehensive definition. Third,
we review and discuss methods for expression tuning. Special
attention is drawn on features relevant to enable expression
tuning on cellular level. Furthermore, their integration to pro-
cess technological methods to achieve expression tuning is
discussed. Fourth, we propose a roadmap for the development
of industrial tunable expression systems. Finally, in an outlook
chapter, we discuss the applicability and benefits of tunable
expression systems for more efficient bioprocessing and the
acceleration of bioprocess development.
Tuning—paving the way for continuous processing
in biopharmaceutical industry
While continuous manufacturing is widely applied across in-
dustries including the petrochemical, food, and pharmaceuti-
cal sectors, it is still outnumbered by batch and semi-batch
processes in the biopharmaceutical industry (Konstantinov
and Cooney 2014). Though downstream and product formu-
lation unit operation already use continuous processing, it is
hardly employed in upstream processing. In addition to logis-
tic barriers like challenging implementation and validation
complexity, continuous processing suffered from process in-
herent obstacles like culture instability, lack of process con-
trol, and sterility issues (Farid et al. 2014; Stock et al. 2014).
However, the demand for flexible manufacturing facilities and
reducing cost of goods is increasing due tomarket fluctuations
and growing competition from biosimilars (Kelley 2009;
Stock et al. 2014; Walsh 2014; Warikoo et al. 2012). With
new technologies emerging in the course of the PAT initiative,
the upswing of continuous processing is also welcomed and
supported by regulatory authorities (Lee et al. 2015; Myerson
et al. 2015). From a regulatory or process technological point
of view, many obstacles did decrease or vanish. However,
culture stability is still an issue (Nancib and Boudrant 1992).
By reducing the protein expression level, cells can be longer
maintained in a producing state. Expression tuning can there-
fore offer a great benefit and act as an enabling tool for con-
tinuous processing. In contrast to just using a low producing
mutant strain, a tunable host offers the possibility to vary the
protein expression online and therefore provides a novel de-
gree of freedom to maneuver an out-of-specs process, back
into the design space.
Defining tunable recombinant protein expression
Although many authors refer to Btunable recombinant protein
expression^ for various purposes, to our knowledge, a clear
Time
qp
Fig. 1 By reducing the protein expression level, the cells can be
maintained in a productive state for a longer time, which results in
higher end product titers (qp specific cellular productivity)
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and uniform definition is still missing in literature. Some au-
thors refer to Btuning^ of expression or gene dosage as
adjusting the plasmid copy number (Camps 2010; Xu et al.
2013), which can also unintentionally be submitted to change
in course of the bioprocess (Teich et al. 1998). Another definition
of tuning of expression refers to the modulation of promoter
strength by construction of a set of promoters of different
strengths through promoter engineering (Alper et al. 2005;
Brewster et al. 2012; Dehli et al. 2012; Mey et al. 2007). In these
cases, the actual tuning is achieved through genetic engineering.
Furthermore, the adjustment of the expression level via simple
process parameters such as temperature andmedium composition
is sometimes termed expression tuning as well (Correa and
Oppezzo 2011). Tuning is often referred to as adjusting the pro-
duction of recombinant proteins on cellular level, whereby tuning
solely on population level (e.g., the formation of subpopulations)
is clearly excluded from the definition (Khlebnikov et al. 2002;
Lee and Keasling 2005; Striedner et al. 2003). However, this
definition only considers the tuning with respect to specific titer
and not the specific cellular productivity (qp), which is varying
along the production period (Sagmeister et al. 2014). When
speaking of tuning of qp, one has to bear in mind that this defini-
tion does not consider the location of the bottlenecks for recom-
binant protein production, whereby either transcription, transla-
tion, translocation, or folding of recombinant proteins can be
bottlenecking (Baneyx and Mujacic 2004; Brinkmann et al.
1989; Harris and Kilby 2014; Tegel et al. 2011; Wagner et al.
2007) (Eq. 1). Keeping in mind that the effective specific cellular
productivity (qp_eff) is actually composed of qp and the product
degradation rate (qdegradation) (Eq. 2), we propose the following
definition for expression tuning:
Expression tuning is referred to as the purposeful adjust-
ment of the recombinant gene transcription rate on cellular
level.
qp ¼ min qtranscription; qtranslation; qtranslocation;ð Þqfolding
 
ð1Þ
qp eff ¼ qp−qdegradation ð2Þ
Formation of subpopulations of producing
and non-producing cells (bistable behavior)—an
impediment to expression tuning
Following the presented definition of expression tuning, it is
of utmost importance to understand, consider, and make it
impossible that observed tuning on population level might
be attributed to the formation of subpopulations of producing
and non-producing cells. If this is the case, tuning of the ex-
pression levels is not achieved, which is also called Bbistable
behavior,^ referring to the formation of two subpopulations.
Homogeneous expression on cellular level is also often
termed Bgraded response.^ Here, knowledge on the mecha-
nisms that lead to these Ball-or-none induction phenomena^
is reviewed.
Novick andWeiner (1957) identified for the lac operon that
apparent tuning on population level may be the result of the
formation of subpopulations of fully induced and non-induced
cells (all-or-none induction, bistability). This was confirmed
by Maloney and Rotman (1973). They observed that the in-
ducer amount only influenced the number of induced cells
rather than the transcription rate on cellular level and proposed
a model describing this phenomenon (Novick and Weiner
1957). Forty years later, Siegele and Hu (1997) reported this
behavior for the arabinose utilization pathway. Further studies
using mechanistic modeling and single cell analytics investi-
gated autocatalytic systems and the switching kinetics of in-
ducible systems (Carrier and Keasling 1999; Fritz et al. 2014;
Megerle et al. 2008; Ozbudak et al. 2004). Afroz et al. (2014b)
investigated and compared eight metabolic pathways of E.
coli with respect to all-or-none behavior and created a deter-
ministic model. Their model related the type of response
(graded or bistable) to the strength of positive feedback (in-
ducible inducer transport) and negative feedback (inducible
inducer catabolism). Bistable responses were expected for
low negative feedback and high positive feedback and graded
responses for high negative feedback and low positive feed-
back. The extent of bistability of different pathways is be-
lieved to be influenced by cooperativity in the expression of
pathway transporters (Afroz et al. 2014b).
General strategies to achieve tuning
Based on the insights in the mechanistic that lead to unwanted
bistable behavior (formation of subpopulations of producing
and non-producing cells), several strategies based on targeted
engineering of metabolic pathways have been reported.
Several authors perform knockout of genes for inducer
transport to omit bistable responses (Afroz et al. 2014b;
Khlebnikov et al. 2000; Marbach and Bettenbrock 2012).
The knockout of transport genes breaks the positive feedback
of the inducer on the production of its own transport proteins
and eliminates the bistable behavior (Afroz et al. 2014a; Fritz
et al. 2014; Khlebnikov et al. 2000). Using inducer transport
knockout strains, induction can be achieved by induction with
gratuitous inducers (Marbach and Bettenbrock 2012) or by
induction with the natural inducer. While some gratuitous in-
ducers can enter the cell passively by diffusing through the
membrane, some natural inducers have to be actively
transported into it. Introducing a separate copy of the trans-
porter gene under control of a different promoter enables in-
ducer to be transported into the cell while avoiding the posi-
tive feedback (Afroz et al. 2014a; Khlebnikov et al. 2000).
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In another approach Wagner et al. constructed a strain,
termed Lemo21(DE3), where the widely used BL21(DE3)
(Studier and Moffatt 1986) was modified by addition of a
vector harboring T7 lysozyme under control of the rhaBAD
promoter. Modulation of T7 lysozyme expression, a natural
inhibitor of T7 polymerase, by varying the rhamnose concen-
tration was reported to convert the all-or-none response of the
BL21(DE3) strain to a uniform response (Schlegel et al. 2012;
Wagner et al. 2008).
We recently showed for the araBAD operon that the use of
metabolizable inducer in a mixed-feed environment results in
a graded response (Sagmeister et al. 2013b). By using an
E. coli strain with intact arabinose operon, we were able to
tune protein expression with arabinose as metabolizable in-
ducer. Using this strategy, the recombinant protein expression
can be tuned by simply adjusting the uptake rate of the induc-
ing substrate.
Process technological aspects of expression tuning
To our knowledge, expression tuning has so far only found
little application in studies using bioreactors and even only in
fed-batch mode (Sagmeister et al. 2013b; Striedner et al.
2003). As far as we know, it has so far not been applied in
continuous processes. When applying expression tuning, the
induction mode is of utmost importance. Within this section,
we review several so far used induction strategies and discuss
them with respect to expression tuning.
One-point addition of varying non-metabolizable inducer
concentrations is the most commonly applied method to
achieve expression tuning (Khlebnikov et al. 2002; Lee and
Keasling 2005; Wagner et al. 2008). This is typically used for
investigative studies with small-scale experiments and short
production periods. It is usually assumed that the concentra-
tion of inducer per cell (specific inducer concentration) is con-
stant. While this assumption is justifiable for small-scale
shake flask experiments, it definitely does not hold true for
industrial fermentation processes. Here, the specific concen-
tration of active inducer can be submitted to change due to
catabolism, dilution by growth and inactivation, for example,
through acetylation (Marbach and Bettenbrock 2012; Novick
and Weiner 1957).
When exploiting tunable systems for industrial
bioprocesses with extended production phase, a continuous
inducer supply is necessary to ensure a constant inducer con-
centration within the cell (Fig. 2). As this criterion is hard to
meet, a possible simplification is to neglect the inducer con-
sumption and transporting rates in and out of the cell and
simply adjust the inducer amount to the biomass concentra-
tion. A method that compensates for these effects, is the con-
tinuous feeding of inducer in order to achieve a constant
inducer-to-biomass ratio (Striedner et al. 2003), which
requires a continuous estimate of biomass concentration. A
possible way to achieve that is to use an exponential feeding
profile and adjust the inducer concentration to the calculated
value according to the feeding profile. These feed-forward
strategies assume a constant yield of biomass on substrate
(Yx/s) and neglect the fact that Yx/s can change especially in
production phases. Therefore, a more accurate method is to
estimate the biomass based on online accessible data with soft
sensors (Luttmann et al. 2012; Paulsson et al. 2014;
Sagmeister et al. 2013c; Wechselberger et al. 2013). The type
of inducer (metabolizable or non-metabolizable) results in
several consequences with respect to the controllability of
the system. When using a non-metabolizable inducer, the in-
duction rate can be independently controlled from the sub-
strate uptake rate (or respectively the specific growth rate).
When using metabolizable inducers as sole carbon source,
the induction rate is tightly coupled to the sugar uptake rate
and therefore cannot be controlled independently.
Another alternative is the application of a mixed-feeding
strategy, where multiple carbon sources are fed to the cells in
certain ratios. The mixed-feed strategy permits the use of me-
tabolizable inducer while retaining the advantage of indepen-
dent control of induction rate and substrate uptake rate (which
determines the specific growth rate). Recently, we demonstrat-
ed the tunability of a system via adjusting the uptake rates of
two sugars: one acting as carbon source and the other as in-
ducer and second carbon source (Sagmeister et al. 2013b).
Independent control of sugar uptake rates can be achieved
via generic control strategies for fed-batch processes
(Sagmeister et al. 2013c). For mixed-feed systems, catabolite
repression poses a natural limitation to the application of these
systems, which has to be investigated beforehand and consid-
ered for process design (Sagmeister et al. 2013a).
However, when adjusting the inducer amount solely to the
cell concentration, the change in the cells’ metabolic load
caused by protein expression is not accounted for. In order
to do so, the metabolic load needs to be quantified. A possible
solution for this matter was provided by Kraft et al. (2007).
They created a reporter system based on the firefly luciferase
gene lucA under the control of a σ32-dependent promoter. The
heat-shock response caused by formation of mis-folded pro-
teins and aggregates led to expression of luciferase, showing a
linear dependency. Higher amounts of mis-folded proteins led
to higher luminescence values (Kraft et al. 2007). By render-
ing the metabolic load accessible to quantification, such re-
porter systems could allow to use tunable systems in a more
accurate way. However, to our knowledge, feedback control
of protein expression based on the metabolic load of the host
has not been performed so far.
As described, expression tuning has been technologically
implemented in various ways, which significantly differ in the
degree of freedoms they leave with respect to process control.
Two methods have to be highlighted for providing the highest
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degree of freedom while containing full controllability of the
process: inducer titration with gratuitous inducer and mixed-
feeding strategy with a metabolizable inducer as second car-
bon source. Both methods enable the independent control of
specific growth rate and induction rate (Fig. 3).
A short outline of currently applied induction methods is
given in Table 1.
How to apply tuning
Verification and evaluation of expression tuning
With respect to the definition as the adjustment of the recombi-
nant gene transcription rate on cellular level, several things have
to be considered in order to demonstrate expression tuning. First
of all, culture homogeneity needs to be verified in order not to
mistake tuning on population level with tuning on cellular level.
The use of a fluorescence reporter protein with suitable analytical
methods has now established itself in order to prove expression
on cellular level. Where flow cytometry (Khlebnikov et al. 2002;
Lee and Keasling 2005; Sagmeister et al. 2013b; Wagner et al.
2008) is more commonly used for bioprocesses, microscopy is
rather used for investigational studies on induction kinetics and
behavior (Megerle et al. 2008; Ozbudak et al. 2004; Siegele and
Hu 1997). Other important aspects have to be addressed when
investigating bioprocesses: outgrowth of segregants, where non-
producing cells outgrow producing cells, can be caused by loss
of plasmids (Krone et al. 2007; Smith and Bidochka 1998) or all-
or-none induction (Novick and Weiner 1957). The transcription
rate of the used promoter might change during the process ac-
cording to its response time (Lee and Keasling 2005). Regarding
these time-dependent effects, it is necessary to gather time-
resolved data to be able to attribute the observed responses to
the right causes. After verification of the tunable system, its
performance needs to be evaluated. In order to gain physiological
knowledge, it is also well established to compare specific con-
centrations (related to biomass concentration or cell number)
(Khlebnikov et al. 2002; Lee and Keasling 2005) rather than
volumetric concentrations.
Furthermore, it needs to be considered that the specific
cellular productivity (qp) is varying along the production pe-
riod (Sagmeister et al. 2014). This behavior is not reflected if
solely end-point-specific concentrations are monitored.
In order to define comparable criteria when working with
tunable systems we recommend the following strategy:
1. Use of fluorescent reporter protein and suitable analytical
methods (flow cytometry or microscopy)
2. Time-resolved acquisition of product data
3. Specific cellular productivity as target variable
Considering the maturity of tunable expression technolo-
gies, we anticipate that in the future, more studies will focus
on the investigation and characterization of tunable systems in
industrially relevant fermentation processes.
Prerequisites for expression tuning on cellular level
From the reviewed literature, general concepts for prerequi-
sites for expression tuning on cellular level can be abstracted.
Above all, a tunable promoter system is the fundamental re-
quirement for expression tuning. For better control, it is im-
portant tomaintain a constant inducer concentration within the
cell. When designing inducible systems, it is therefore neces-
sary to consider all possible routes for inducer concentration
changes within the cell such as transport in and out of the cell,
assimilation, and change of the specific inducer concentration
due to cell growth. A large dynamic range of tunability with
respect to inducer concentrations is of advantage.
Inactivation/
Export Metabolism
Induction
Inducer Titration
Indepedent 
control of 
uptake ratesInducer
Main Substrate
Fig. 2 In order to maintain a constant expression level under
subsaturating inducer concentrations, a constant inducer concentration
within the cell is mandatory. Therefore, all routes of transport into
(active import, diffusion) and out of the cell (metabolism, inactivation,
export) have to be considered. As not all of these rates are accessible, a
constant inducer concentration within the cell can only be approximated.
When using non-metabolizable inducers, this condition can be
approximated by adjusting the extracellular inducer concentration to the
biomass concentration. In the case of metabolizable inducers, a mixed-
feeding strategy, where the uptake of the main substrate and inducing
substrate can be controlled independently, needs to be applied in order
to retain the additional degree of freedom of expression tuning
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Furthermore, plasmid stability is necessary. Otherwise, the
transcription of each gene copy is controlled, but protein ex-
pression per cell varies due to different amounts of plasmid
copy number and results in an inhomogeneous culture
(Khlebnikov et al. 2000). Therefore, the use and proof of
stable plasmids or genome integration of the expression se-
quence is mandatory. Despite of its stability, the plasmid copy
number of the used vector itself needs to be considered.
Whether the use of a low-, medium- or high-copy number
plasmid is possible, depends on the strength of the used
tunable promoter system. The direct controllability of protein
expression by transcription tuning is only possible as long as
transcription is the limiting step for recombinant protein pro-
duction. It might happen that a weak promoter on a high-copy
number plasmid already exceeds these limits and other steps
rather than transcription become the bottleneck in recombi-
nant protein production. This loss of controllability can finally
lead to a decrease of product quality (aggregation, amino acid
incorporation, etc.) (Harris and Kilby 2014; Kane and Hartley
1991) or lead to a loss of plasmids (Chang et al. 2003). In
order to receive more controllability, the tightness of the used
expression system needs to be taken into consideration. Basal
product expression can sometimes be a major issue as it is for,
e.g., membrane protein production (Giacalone et al. 2006;
Wagner et al. 2007).
Other prerequisites valid for Bthe ideal expression system^
also apply to tunable expression systems and are discussed
elsewhere (Keasling 1999; Rosano and Ceccarelli 2014).
Expression tuning also an opportunity for process
development and scientific progress
Combined with process technology, tunable expression sys-
tems enable the control of the recombinant protein expression
Transcription
Translation
Inducer
uptake rate
growth rate
Transcription
Translation
Inducer
uptake rate
growth rate
Susbtrate
uptake rate
Transcription
Translation
Inducer
uptake rate
growth rate
Susbtrate
uptake rate
Transcription
Translation
Inducer
uptake rate
growth rate
Susbtrate
uptake rate
BA
DC
Fig. 3 For expression tuning, several induction strategies have been
used. One-point addition of non-metabolizable inducer (a) is commonly
applied, but provides no novel degree of freedom for process control. The
inducer concentration is only added at the timepoint of induction and not
adjusted throughout the process. It is therefore submitted to change due to
catabolism, dilution by growth, and inactivation. By inducer titration, the
inducer concentration is continuously added to the culture and
concentration changes can therefore be accounted for. When using
a metabolizable inducer for inducer titration (b), the specific growth rate
and the protein expression cannot be controlled individually as the
inducer acts as substrate as well. Independent control of specific growth
rate and protein expression rate and therefore a novel degree for process
control is gained when performing inducer titration with non-
metabolizable inducers (c). In this case, addition of substrate controls
the specific growth rate and addition of inducer controls the induction
rate. Another way to retain this novel degree of freedom is to use
metabolizable inducers in a mixed-feed environment (d). Here, specific
growth rate is controlled by addition of main substrate and inducing
substrate and induction rate is controlled by the ratio of inducing
substrate to main substrate. For reasons of easier comprehensibility, the
overall influence of specific growth rate on protein expression is not
illustrated in this graphic representation
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rate using process technological means. With the use of a
suitable control strategy, the transcription rate can be indirect-
ly controlled. Subsequently, this can be considered in process
development and process optimization, for example, using
design-of-experiment approaches (Mandenius and Brundin
2008). Expression tuning using process technological means
adds a novel degree of freedom to the design of recombinant
processes. Using the reviewed technologies, it is possible to
fine-tune recombinant protein expression to a level which ex-
ploits the cell factory to a maximum. This optimization can
take place in controlled lab-scale bioreactor experiments,
which more accurately reflects industrial processes that
screening studies in shake flasks.
In the field of enzyme control analysis, it is neces-
sary to use promoters of different strengths in order to
investigate different molecular fluxes within the cell
(Jensen et al. 1993). This approach involves the con-
struction of different constructs for different concentra-
tions of observed enzymes. We anticipate that the con-
struction of only one tunable construct to cover all
cases would be a great benefit for the investigation
and optimization of metabolic pathways. Possible fields
of applications for expression tuning are summarized in
Table 2.
Conclusions and outlook
Within this contribution, we provide an overview of chal-
lenges and applications of state-of-the-art methods and tech-
nologies for expression tuning in E. coli. Furthermore, we
attempt to provide a clear and precise definition for expression
tuning: as the etymology of tuning meets more the conception
of stepping on the accelerator pedal than on building a whole
new car in order to make your car go faster, we anticipate to
use the term tuning as the purposeful adjustment of the recom-
binant gene transcription rate on cellular level.
To date, one-point addition of inducer is the most prevail-
ing process technological method to achieve expression
tuning. However, due to inherent problems such as degrada-
tion of inducer and a lack of process technological control
over the tuning process, we anticipate that other process tech-
nological methods such as the use of metabolizable inducers,
inducer titration, and mixed-feed strategies will gain impor-
tance in the future. We anticipate that expression tuning will
unfold its full benefits only in combination with adequate
control strategies. Hence, these methods will be essential for
the industrial exploitation of tunable expression systems.
Considering the broad spectrum of mature methods and
technologies as well as the broad scientific knowledge
Table 1 Process technological methods for expression tuning
Induction method Mode of action Comments
One-point addition of inducer The concentration of inducer is adjusted to a defined
concentration in the beginning of the induction phase
Widely applied, however, inducer concentration can
change throughout the process due to catabolism,
dilution by growth, or inactivation (Marbach and
Bettenbrock 2012; Novick and Weiner 1957)
Inducer titration Non-metabolizable inducer is continuously supplied to
keep the specific inducer concentration
(inducer/biomass) constant
Independent control of sugar uptake rate (growth rate)
and induction rate is possible (Striedner et al. 2003)
Metabolizable inducer Metabolizable inducer is continuously supplied and
metabolized by the cells
Induction rate and uptake rate of metabolizable
inducer are tightly coupled
Mixed feed Both primary growth substrate and metabolizable inducer are
simultaneously supplied and metabolized by the cells
Independent control of specific growth rate and
induction rate is possible (Sagmeister et al. 2013a).
Table 2 Use cases for expression tuning
Use case Mode of action Reference
Increase soluble protein titer Prevent unwanted inclusion body formation through
downregulation of expression
(Baig et al. 2014; Kane and Hartley 1991)
Increase active product amount Debottleneck translocation for correct disulfide
bond formation in periplasm
(Baneyx and Mujacic 2004)
Toxic protein expression Tune toxic protein expression to a level which is
tolerated by the host
(Doherty et al. 1993; Dong et al. 1995)
Reduce metabolic load Enable longer production periods and increase
product quality by lowering the burden on the host and
its protein expression machinery
(Bentley et al. 2009; Bienick et al. 2014; Glick 1995;
Mairhofer et al. 2013)
Substitute and supplement to
promoter libraries
Facilitate enzyme control analysis by using a tunable promoter
instead of several promoters of different strengths
(Alper et al. 2005; Dehli et al. 2012; Mey et al. 2007)
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available, we anticipate that expression tuning will soon be
adapted by industry as generically applicable tool to enable
and optimize the production of a broad spectrum of products
in E. coli. By enabling online controllability of protein expres-
sion, we believe that expression tuning is able to tackle the
issues of constant product quality and culture long-term stabil-
ity and therefore will pave the way for continuous production of
biopharmaceuticals. This in turn will further progress E. coli as
the primary expression platform for recombinant products
intended for pharmaceutical or technical use.
Acknowledgments Open access funding provided by TU Wien
(TUW).
Compliance with ethical standards This article does not contain any
studies with human participants or animals performed by any of the authors.
Conflict of interest The authors declare that they have no conflict of
interest.
Open Access This article is distributed under the terms of the Creative
Commons At t r ibut ion 4 .0 In te rna t ional License (h t tp : / /
creativecommons.org/licenses/by/4.0/), which permits unrestricted use,
distribution, and reproduction in any medium, provided you give appro-
priate credit to the original author(s) and the source, provide a link to the
Creative Commons license, and indicate if changes were made.
References
Afroz T, Biliouris K, Boykin KE, Kaznessis Y, Beisel CL (2014a) Trade-
offs in engineering sugar utilization pathways for titratable control.
ACS Synthetic Biology:140806162654005 doi:10.1021/sb400162z
Afroz T, Biliouris K, Kaznessis Y, Beisel CL (2014b) Bacterial sugar
utilization gives rise to distinct single-cell behaviours. Molecular
Microbiology:n/a. doi:10.1111/mmi.12695
Alper H, Fischer C, Nevoigt E, Stephanopoulos G (2005) Tuning genetic
control through promoter engineering. Proc Natl Acad Sci 102(36):
12678–12683. doi:10.1073/pnas.0504604102
Baig F, Fernando LP, Salazar MA, Powell RR, Bruce TF, Harcum
SW (2014) Dynamic transcriptional response of Escherichia
coli to inclusion body formation. Biotechnol Bioeng 111(5):
980–999. doi:10.1002/bit.25169
Baneyx F, Mujacic M (2004) Recombinant protein folding and
misfolding in Escherichia coli. Nat Biotechnol 22(11):1399–1408.
doi:10.1038/nbt1029
BentleyWE,Mirjalili N, Andersen DC, Davis RH, Kompala DS,William
E, Bentley I (2009) Plasmid-encoded protein: The principal factor in
the Bmetabolic burden^ associated with recombinant bacteria.
Biotechnol Bioeng 102(5):1283–1297. doi:10.1002/bit.22292
Bienick MS, Young KW, Klesmith JR, Detwiler EE, Tomek KJ,
Whitehead TA, Fong SS (2014) The interrelationship between pro-
moter strength, gene expression, and growth rate. PLoS One 9(10):
e109105. doi:10.1371/journal.pone.0109105
Brewster RC, Jones DL, Phillips R, van Nimwegen E (2012)
Tuning promoter strength through RNA polymerase binding
site design in Escherichia coli. PLoS Comput Biol 8(12):
e1002811. doi:10.1371/journal.pcbi.1002811
Brinkmann U, Mattes RE, Buckel P (1989) High-level expression
of recombinant genes in Escherichia coli is dependent on the
availability of the dnaY gene product. Gene 85(1):109–114.
doi:10.1016/0378-1119(89)90470-8
Camps M (2010) Modulation of ColE1-like plasmid replication for recom-
binant gene expression. Recent patents on DNA & gene sequences
4(1):58–73
Carrier TA, Keasling JD (1999) Investigating autocatalytic gene expres-
sion systems through mechanistic modeling. J Theor Biol 201(1):
25–36. doi:10.1006/jtbi.1999.1010
Chang T-S, Wu W-J, Wan H-M, Shiu T-R, Wu W-T (2003) High-
level expression of a lacZ gene from a bacterial artificial
chromosome in Escherichia coli. Appl Microbiol Biotechnol
61(3):234–239. doi:10.1007/s00253-003-1252-4
Correa A, Oppezzo P (2011) Tuning different expression parame-
ters to achieve soluble recombinant proteins in E. coli:
Advantages of high-throughput screening. Biotechnol J 6(6):
715–730. doi:10.1002/biot.201100025
Dehli T, Solem C, Jensen PR (2012) Tunable promoters in synthetic and
systems biology. In: Wang X, Chen J, Quinn P (eds) Reprogramming
microbial metabolic pathways, Subcellular Biochemistry, vol 64.
Springer Netherlands, Dordrecht, pp. 181–201
Doherty AJ, Connolly BA, Worrall AF (1993) Overproduction of the
toxic protein, bovine pancreatic DNasel, in Escherichia coli using
a tightly controlled T7-promoter-based vector. Gene 136(1–2):337–
340. doi:10.1016/0378-1119(93)90491-k
Dong H, Nilsson L, Kurland CG (1995) Gratuitous overexpression of
genes in Escherichia coli leads to growth inhibition and ribosome
destruction. J Bacteriol 177(6):1497–1504
Farid SS, Pollock J, Ho SV (2014) Evaluating the economic and opera-
tional feasibility of continuous processes for monoclonal antibod-
ies.433–456 doi:10.1002/9783527673681.ch17
Fritz G, Megerle JA, Westermayer SA, Brick D, Heermann R, Jung K,
Rädler JO, Gerland U, Herman C (2014) Single cell kinetics of
phenotypic switching in the arabinose utilization system of E. coli.
PLoS One 9(2):e89532. doi:10.1371/journal.pone.0089532
Giacalone M, Gentile A, Lovitt B, Berkley N, Gunderson C, Surber M
(2006) Toxic protein expression in Escherichia coli using a
rhamnose-based tightly regulated and tunable promoter system.
Biotechniques 40(3):355–364. doi:10.2144/000112112
Glick BR (1995) Metabolic load and heterologous gene expression.
Biotechnol Adv 13(2):247–261. doi:10.1016/0734-9750(95)00004-a
Harris RP, Kilby PM (2014) Amino acid misincorporation in recombinant
biopharmaceutical products. Curr Opin Biotechnol 30:45–50. doi:
10.1016/j.copbio.2014.05.003
Hellmuth K, Korz DJ, Sanders EA, Deckwer W-D (1994) Effect of
growth rate on stability and gene expression of recombinant plas-
mids during continuous and high cell density cultivation of
Escherichia coli TG1. J Biotechnol 32(3):289–298. doi:10.1016/
0168-1656(94)90215-1
Jensen PR, Westerhoff HV, Michelsen O (1993) The use of lac-type
promoters in control analysis. European journal of biochemistry/
FEBS 211(1–2):181–191
Kane JF, Hartley DL (1991) Properties of recombinant protein-
containing inclusion bodies in Escherichia coli. Bioprocess
technology 12(16):121–145
Keasling JD (1999) Gene-expression tools for the metabolic engi-
neering of bacteria. Trends Biotechnol 17(11):452–460. doi:
10.1016/s0167-7799(99)01376-1
Kelley B (2009) Industrialization of mAb production technology: the
bioprocessing industry at a crossroads. mAbs 1(5):443–452
Khlebnikov A, Risa O, Skaug T, Carrier TA, Keasling JD (2000)
Regulatable arabinose-inducible gene expression system with con-
sistent control in all cells of a culture. J Bacteriol 182(24):7029–
7034. doi:10.1128/jb.182.24.7029-7034.2000
5726 Appl Microbiol Biotechnol (2016) 100:5719–5728
Khlebnikov A, Skaug T, Keasling JD (2002) Modulation of gene expres-
sion from the arabinose-inducible araBAD promoter. J Ind
Microbiol Biotechnol 29(1):34–37. doi:10.1038/sj.jim.7000259
Konstantinov KB, Cooney C (2014) ISCMP 2014 White Paper 4—
Continuous Bioprocessing. International Symposium on
Continuous Manufacturing of Pharmaceuticals
Kraft M, Knüpfer U, Wenderoth R, Pietschmann P, Hock B, Horn U
(2007) An online monitoring system based on a synthetic
sigma32-dependent tandem promoter for visualization of insoluble
proteins in the cytoplasm of Escherichia coli. Appl Microbiol
Biotechnol 75(2):397–406. doi:10.1007/s00253-006-0815-6
Krone SM, Lu R, Fox R, Suzuki H, Top EM (2007) Modelling the spatial
dynamics of plasmid transfer and persistence. Microbiology 153(8):
2803–2816. doi:10.1099/mic.0.2006/004531-0
Lee SK, Keasling JD (2005) A propionate-inducible expression system
for enteric bacteria. Appl Environ Microbiol 71(11):6856–6862.
doi:10.1128/aem.71.11.6856-6862.2005
Lee SL, O’Connor TF, Yang X, Cruz CN, Chatterjee S, Madurawe RD,
Moore CMV, Yu LX, Woodcock J (2015) Modernizing pharmaceu-
tical manufacturing: from batch to continuous production. J Pharm
Innov 10(3):191–199. doi:10.1007/s12247-015-9215-8
Luttmann R, Bracewell DG, Cornelissen G, Gernaey KV, Glassey J, Hass
VC, Kaiser C, Preusse C, Striedner G, Mandenius C-F (2012) Soft
sensors in bioprocessing: a status report and recommendations.
Biotechnol J 7(8):1040–1048. doi:10.1002/biot.201100506
Mairhofer J, Scharl T, Marisch K, Cserjan-Puschmann M, Striedner G
(2013) Comparative transcription profiling and in-depth characteri-
zation of plasmid-based and plasmid-free Escherichia coli expres-
sion systems under production conditions. Appl Environ Microbiol
79(12):3802–3812. doi:10.1128/aem.00365-13
Maloney PC, Rotman B (1973) Distribution of suboptimally in-
duced β-d-galactosidase in Escherichia coli. J Mol Biol
73(1):77–91. doi:10.1016/0022-2836(73)90160-5
Mandenius CF, Brundin A (2008) Bioprocess optimization using design-
of-experiments methodology. Biotechnol Prog 24(6):1191–1203.
doi:10.1002/btpr.67
Marbach A, Bettenbrock K (2012) lac operon induction in
Escherichia coli: Systematic comparison of IPTG and TMG
induction and influence of the transacetylase LacA. J
Biotechnol 157(1):82–88. doi:10.1016/j.jbiotec.2011.10.009
Megerle JA, Fritz G, Gerland U, Jung K, Rädler JO (2008)
Timing and dynamics of single cell gene expression in the
arabinose utilization system. Biophys J 95(4):2103–2115. doi:
10.1529/biophysj.107.127191
Mey Md, Maertens J, Lequeux GJ, Soetaert WK, Vandamme EJ (2007)
Construction and model-based analysis of a promoter library for
E. coli: an indispensable tool for metabolic engineering. BMC
Biotechnology 7(1):34 doi:10.1186/1472–6750–7-34
MyersonAS, KrummeM, NasrM, Thomas H, Braatz RD (2015) Control
systems engineering in continuous pharmaceutical manufacturing.
May 20–21, 2014 Continuous Manufacturing Symposium. J Pharm
Sci 104(3):832–839. doi:10.1002/jps.24311
Nancib N, Boudrant J (1992) Effect of growth rate on stability and gene
expression of a recombinant plasmid during continuous culture of
Escherichia coli in a non-selective medium. Biotechnol Lett 14(8):
643–648. doi:10.1007/bf01021635
Novick A, Weiner M (1957) Enzyme induction as all-or-none phenome-
non. Proceedings of the National Academy of Sciences(43):553–566
Ozbudak EM, That ta i M, Lim HN, Shra iman BI, van
Oudenaarden A (2004) Multistability in the lactose utilization
network of Escherichia coli. Nature 427(6976):737–740. doi:
10.1038/nature02298
Paulsson D, Gustavsson R, Mandenius CF (2014) A soft sensor for
bioprocess control based on sequential filtering of metabolic heat sig-
nals. Sensors (Basel) 14(10):17864–17882. doi:10.3390/s141017864
Rodríguez-Carmona E, Cano-Garrido O, Dragosits M, Maurer M,
Mader A, Kunert R, Mattanovich D, Villaverde A, Vázquez
F (2012) Recombinant Fab expression and secretion in
Escherichia coli continuous culture at medium cell densities:
Influence of temperature. Process Biochem 47(3):446–452.
doi:10.1016/j.procbio.2011.11.024
Rosano GL, Ceccarelli EA (2014) Recombinant protein expression in
Escherichia coli: advances and challenges. Front Microbiol 5. doi:
10.3389/fmicb.2014.00172
Sagmeister P, Jazini M, Klein J, Herwig C (2014) Bacterial suspension
cultures. In: Meyer H-P, Schmidhalter DR (eds) Industrial scale
suspension culture of living cells. pp 41–90
Sagmeister P, Kment M, Wechselberger P, Meitz A, Langemann T,
Herwig C (2013a) Soft-sensor assisted dynamic investigation of
mixed feed bioprocesses. Process Biochem 48(12):1839–1847.
doi:10.1016/j.procbio.2013.09.018
Sagmeister P, Schimek C, Meitz A, Herwig C, Spadiut O (2013b)
Tunable recombinant protein expression with E. coli in a mixed-
feed environment. Applied Microbiology and Biotechnology doi:
10.1007/s00253-013-5445-1
Sagmeister P,Wechselberger P, Jazini M,Meitz A, Langemann T, Herwig
C (2013c) Soft sensor assisted dynamic bioprocess control: efficient
tools for bioprocess development. Chem Eng Sci 96:190–198. doi:
10.1016/j.ces.2013.02.069
Schlegel S, Löfblom J, Lee C, Hjelm A, Klepsch M, Strous M, Drew D,
Slotboom DJ, J-Wd G (2012) Optimizing membrane protein over-
expression in the Escherichia coli strain Lemo21(DE3). J Mol Biol
423(4):648–659. doi:10.1016/j.jmb.2012.07.019
Siegele DA, Hu JC (1997) Gene expression from plasmids containing the
araBAD promoter at subsaturating inducer concentrations represents
mixed populations. Proc Natl Acad Sci U S A 94(15):8168–8172
Smith MA, Bidochka MJ (1998) Bacterial fitness and plasmid loss: the
importance of culture conditions and plasmid size. Can J Microbiol
44(4):351–355
Stock LR, Bisschops M, Ransohoff TC (2014) The potential im-
pact of continuous processing on the practice and economics
of biopharmaceutical manufacturing.479–494 doi:10.1002/
9783527673681.ch19
Striedner G, Cserjan-Puschmann M, Potschacher F, Bayer K (2003)
Tuning the transcription rate of recombinant protein in strong
Escherichia coli expression systems through repressor titration.
Biotechnol Prog 19(5):1427–1432. doi:10.1021/bp034050u
Studier FW, Moffatt BA (1986) Use of bacteriophage T7 RNA polymer-
ase to direct selective high-level expression of cloned genes. J Mol
Biol 189(1):113–130. doi:10.1016/0022-2836(86)90385-2
Tegel H, Ottosson J, Hober S (2011) Enhancing the protein production
levels in Escherichia coli with a strong promoter. FEBS J 278(5):
729–739. doi:10.1111/j.1742-4658.2010.07991.x
Teich A, Lin HY, Andersson L, Meyer S, Neubauer P (1998)
Amplification of ColE1 related plasmids in recombinant cultures
of Escherichia coli after IPTG induction. J Biotechnol 64(2–3):
197–210. doi:10.1016/s0168-1656(98)00108-4
Wagner S, Baars L, Ytterberg AJ, Klussmeier A, Wagner CS,
Nord O, Nygren P-A, van Wijk KJ, J-Wd G (2007)
Consequences of membrane protein overexpression in
Escherichia coli. Molecular & cellular proteomics: MCP
6(9):1527–1550. doi:10.1074/mcp.M600431-MCP200
Wagner S, Klepsch MM, Schlegel S, Appel A, Draheim R, Tarry
M, Högbom M, van Wijk KJ, Slotboom DJ, Persson JO, J-
Wd G (2008) Tuning Escherichia coli for membrane protein
overexpression. Proc Natl Acad Sci U S A 105(38):14371–
14376. doi:10.1073/pnas.0804090105
Walsh G (2014) Biopharmaceutical benchmarks 2014. Nat Biotechnol
32(10):992–1000. doi:10.1038/nbt.3040
Warikoo V, Godawat R, Brower K, Jain S, Cummings D,
Simons E, Johnson T, Walther J, Yu M, Wright B,
Appl Microbiol Biotechnol (2016) 100:5719–5728 5727
McLarty J, Karey KP, Hwang C, Zhou W, Riske F,
Konstantinov K (2012) Integrated continuous production of
recombinant therapeutic proteins. Biotechnol Bioeng
109(12):3018–3029. doi:10.1002/bit.24584
Wechselberger P, Sagmeister P, Herwig C (2013) Real-time estimation of
biomass and specific growth rate in physiologically variable
recombinant fed-batch processes. Bioprocess Biosyst Eng 36(9):
1205–1218. doi:10.1007/s00449-012-0848-4
Xu P, Gu Q, Wang W, Wong L, Bower AGW, Collins CH, Koffas MAG
(2013) Modular optimization of multi-gene pathways for fatty acids
production inE. coli. Nature. Communications 4:1409. doi:10.1038/
ncomms2425
5728 Appl Microbiol Biotechnol (2016) 100:5719–5728
